KCap Biotechnology Fund LP is a hedge fund based in Boston, Massachusetts. According to its most recent Form D, filed Sep 16, 2026, the fund has sold $24,408,710 of interests to 14 investors since its first sale in Oct 2023. The filing does not set a minimum investment. It relies on the Section 3(c)(1) exclusion, which limits it to 100 beneficial owners, typically accredited investors. The offering uses Rule 506(b), which does not permit general solicitation. Based on its first sale date and the amount raised, AltMountain classifies it as an emerging manager. Related persons named in the filing include Douglas Fambrough; Kuahiwi Capital LLC.
Performance
No verified returns have been reported for this fund. Hedge fund returns are not part of SEC filings; managers report them to AltMountain directly.
Is this your fund? Report your monthly returns · How performance works
- Total raised
- $24,408,710Cumulative sales reported on Form D
- Investors
- 14
- First sale
- Oct 2, 2023
- Minimum investment
- None set
- Who can invest
- Accredited investorsSection 3(c)(1): up to 100 beneficial owners
- Offering exemption
- Rule 506(b)No general advertising
- Key people and entities
- Douglas Fambrough; Kuahiwi Capital LLC
- Latest Form D
- Sep 16, 2026
From SEC filings, not verified. This page republishes the fund's Form D as filed. It is not an offer, solicitation or recommendation, and AltMountain has not reviewed the fund. “Raised” is cumulative sales, not current assets or performance. Private funds are speculative, illiquid and generally limited to accredited investors or qualified purchasers. Full disclosures · Request a correction
Questions about KCap Biotechnology Fund LP
What is the minimum investment for KCap Biotechnology Fund LP?
KCap Biotechnology Fund LP's latest Form D, filed Sep 16, 2026, does not set a minimum investment. Managers can still require one in the offering documents.
Who can invest in KCap Biotechnology Fund LP?
KCap Biotechnology Fund LP is generally open only to accredited investors, and it may have no more than 100 beneficial owners because it relies on Section 3(c)(1). It uses Rule 506(b), which does not allow general advertising.
How much has KCap Biotechnology Fund LP raised?
KCap Biotechnology Fund LP reports $24,408,710 sold from 14 investors on its Form D filed Sep 16, 2026. This is cumulative sales since the offering began, not current assets or performance.
Where is KCap Biotechnology Fund LP based?
KCap Biotechnology Fund LP is based in Boston, Massachusetts.
When did KCap Biotechnology Fund LP launch?
KCap Biotechnology Fund LP reports its first sale in Oct 2023, which makes it an emerging manager by AltMountain's definition (first sale in 2021 or later and under $50 million raised).
Size compared with every hedge fund
Raised more than 25% of the 474 hedge funds based in Massachusetts, and more than 33% of all 10,308 that report sales.